Atherosclerosis Obliterans

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
Endovascular treatment for PAD during medical careN/A1 trial
Active Trials
NCT03020290Completed335Est. Apr 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottEndovascular treatment for PAD during medical care

Clinical Trials (1)

Total enrollment: 335 patients across 1 trials

NCT03020290AbbottEndovascular treatment for PAD during medical care

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents

Start: Dec 2016Est. completion: Apr 2018335 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space